Liothyronine is a synthetic form of T3, one of the two hormones your thyroid gland naturally produces. It’s primarily used to treat hypothyroidism, but it also plays a role in thyroid cancer management, certain diagnostic tests, and occasionally as an add-on treatment for depression. Because T3 is the more active of your two thyroid hormones, liothyronine works faster and clears the body sooner than the more commonly prescribed levothyroxine (a synthetic T4), which gives it a distinct set of uses.
How It Treats Hypothyroidism
Liothyronine is approved to treat hypothyroidism at every level of the system that controls thyroid hormone production. That includes primary hypothyroidism (where the thyroid gland itself is damaged or underactive), secondary hypothyroidism (caused by a pituitary gland problem), and tertiary hypothyroidism (originating in the hypothalamus). It works whether the condition is present from birth or develops later in life.
The standard starting dose for adults is 25 micrograms once a day, with a typical maximum of 75 micrograms daily. Your dose gets adjusted based on blood work. That said, levothyroxine (T4) remains the standard first-line treatment for hypothyroidism. Most people do well on T4 alone because the body converts it into T3 as needed. Liothyronine tends to come into play when that conversion isn’t happening efficiently, or when someone continues to feel symptomatic despite normal lab results on levothyroxine.
Why T3 Differs From T4
Your thyroid gland produces T4 and T3 in roughly a 13:1 ratio, secreting about 85 micrograms of T4 and 6.5 micrograms of T3 each day. T4 acts as a reservoir that your body draws from, slowly converting it to the more biologically active T3. Liothyronine has a half-life of approximately one day, meaning it enters and leaves your system much faster than levothyroxine, which lingers for about a week.
This shorter duration is both an advantage and a limitation. It means liothyronine takes effect quickly, which is useful in certain clinical situations. But it also means blood levels of T3 can spike and dip throughout the day rather than staying steady, which is why some doctors split the daily dose into multiple smaller doses and why levothyroxine remains the default choice for long-term treatment.
Its Role in Thyroid Cancer
In well-differentiated thyroid cancers (papillary, follicular, and oncocytic types), liothyronine serves a dual purpose after surgery or radioactive iodine treatment. First, it replaces the thyroid hormone your body can no longer make on its own. Second, it suppresses TSH, the pituitary hormone that stimulates thyroid tissue. This matters because these cancer cells still have TSH receptors on their surface, so high TSH levels can promote tumor regrowth. Keeping TSH low with thyroid hormone is a form of cancer-directed therapy.
Liothyronine is also useful during the preparation phase for radioactive iodine scans. Patients need to have elevated TSH for these scans to work, which means temporarily stopping thyroid hormone. Because liothyronine clears the body in about a day, patients can stop taking it just two weeks before a scan and reach the necessary TSH levels. Stopping levothyroxine would require a much longer withdrawal period, leaving the patient hypothyroid and symptomatic for weeks longer.
This role does not extend to all thyroid cancers. Medullary thyroid carcinoma originates from C-cells that don’t have TSH receptors, so TSH suppression offers no anti-cancer benefit. In those cases, thyroid hormone is given purely as replacement therapy.
Combination Therapy With Levothyroxine
Some people on levothyroxine alone continue to experience fatigue, brain fog, weight issues, or low mood despite having blood work that looks normal. For these patients, adding a small dose of liothyronine to their existing levothyroxine is sometimes tried. The idea is to more closely mimic what a healthy thyroid produces naturally: both T4 and T3.
The American Thyroid Association acknowledges combination T4/T3 therapy as a potential option, particularly in patients with postsurgical hypothyroidism. However, the evidence base is still developing, and guidelines have been cautious. Levothyroxine alone remains the standard of care. Whether combination therapy helps a broader group of hypothyroid patients is still being studied.
Diagnostic Use in Suppression Tests
Liothyronine is approved as a diagnostic tool in thyroid suppression tests. In this scenario, a doctor gives liothyronine for a set period and then checks how the thyroid responds. In a normally functioning thyroid, the extra T3 signals the pituitary to reduce TSH, which causes the thyroid to quiet down. If the thyroid keeps producing hormone despite the suppressed TSH, it suggests autonomous thyroid tissue, pointing toward mild hyperthyroidism or a hot nodule that’s functioning independently.
Off-Label Use for Depression
Liothyronine has a long history of use as an add-on treatment for depression that hasn’t responded to antidepressants alone. In the STAR*D trial, one of the largest studies on treatment-resistant depression, patients who hadn’t improved after two rounds of antidepressant medication were given T3 at doses up to 50 micrograms per day for up to 14 weeks. Other studies have used similar doses (25 to 50 micrograms daily) alongside SSRIs.
The rationale is that thyroid hormones influence brain chemistry, and even subtle thyroid imbalances that don’t show up on standard blood tests may contribute to persistent low mood. This use is well known among psychiatrists, though it remains off-label and is typically reserved for cases where standard treatments have fallen short.
Side Effects and Safety Profile
The most common concerns with liothyronine relate to getting too much thyroid hormone, which can cause symptoms of thyrotoxicosis: a racing heart, palpitations, anxiety, tremor, and weight loss. Case reports have documented persistent rapid heart rate and, in rare instances, atrial fibrillation in patients taking liothyronine, particularly at higher doses or when the medication was prescribed in error.
However, a large meta-analysis covering more than 630,000 patients found no statistically significant increase in atrial fibrillation, heart failure, or stroke among liothyronine users compared to those on levothyroxine alone. Earlier concerns from studies in the 1960s appear to have been driven by excessive dosing rather than something inherent to T3 itself. At appropriate doses with proper monitoring, liothyronine’s cardiovascular risk profile appears comparable to levothyroxine.
What Liothyronine Is Not Used For
Liothyronine is not indicated for shrinking benign thyroid nodules or treating nontoxic goiter in people who get enough iodine in their diet. It’s also not appropriate during the recovery phase of subacute thyroiditis, a temporary inflammation of the thyroid that typically resolves on its own. In both cases, the risks of adding T3 outweigh any potential benefit.